UnknownPhase 4

Use of Warfarin After the First Trimester in Pregnant Women With APS

Egypt100 participantsStarted 2014-11

Plain-language summary

Evaluation of shifting to oral vitamin K antagonist after the first trimester instead of using low molecular weight heparin (LMWH) throughout pregnancy in pregnant women with antiphospholipid syndrome (APS)

Who can participate

Age range20 Years – 38 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women with APS diagnosed according to the revised classification criteria for APS in 2006 in Sydney, Australia * Early pregnancy body weight is 50-90 Kg Exclusion Criteria: * Women with systemic lupus erythematosus (SLE) * Women with active thromboembolic disorders * Women with history of previous thromboembolic disorders

What they're measuring

Fetal loss

Timeframe: From 12 weeks to 42 weeks gestational age

Trial details

NCT IDNCT02303171

SponsorMohamed Sayed Abdelhafez

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12

Contact for this trial

Mohamed I Eid, Dr

+201225401274 dr_moh_eid@yahoo.com

View on ClinicalTrials.gov More Recurrent Miscarriage trials